Topics
Meningioma | Treatment | Clinical trials | Vismodegib
Home > Publications > Topics > Meningioma > Treatment > Clinical trials > Vismodegib
Tsao AS, Song Z, Ho AL, Mehnert JM, Ivy P, Gray RJ, Wang V,
McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR,
Takebe N, Ajumally R, Silhavy J, Rahmanian S, Das B, Chen L,
Karlovich C, Lococo JS, Tricoli JV, Conley BA, Arteaga CL, Harris
LN, O'Dwyer PJ, Chen AP, Flaherty KT.
Phase
II Study of Vismodegib in Patients With SMO-
or PTCH1-Mutated
Tumors: Results From the National Cancer Institute Molecular
Analysis for Therapy Choice Eastern Cooperative Oncology
Group-American College of Radiology Imaging Network Trial (EAY131)
Subprotocol T.
JCO
Precis Oncol. 2025 Oct 9;9:e2500119. doi:
10.1200/PO-25-00119. PMID:
41066729. Interventional study˰
ˍ